The Serbian Competition Authority confirms fines against 12 pharmaceutical companies for entering into a restrictive agreement (Hemofarm)

On 26 January 2012 the Commision for the Protection of Competition of the Republic of Serbia (the "Competition Authority") issued a decision setting the amount of fines for 12 pharmaceutical companies (Hemofarm a.d., Galenika a.d., Zdravlje Leskovac a.d., Jugoremedija a.d., Slaviamed d.o.o., Pharma Swiss d.o.o., Velefarm a.d., Vetfarm a.d., Farmalogist d.o.o., Phoenix Pharma d.o.o., Jugohemija-farmacija d.o.o., Unihemkom d.o.o.), which the Competition Authority had found guilty of anticompetitive practices in its decision of 12 December 2008. History of the case In 2008, the Competition Authority, following a request from a wholesaler of pharmaceutical products (Radakom d.o.o.), initiated an investigation concerning anticompetitive practice in the pharmaceutical sector which brought

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Authors

Quotation

Mirko Lalatovic, Tijana Arsenijevic, The Serbian Competition Authority confirms fines against 12 pharmaceutical companies for entering into a restrictive agreement (Hemofarm), 26 January 2012, e-Competitions Bulletin Rebates, Art. N° 45901

Visites 292

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues